Microcalcification crystallography as a potential marker of DCIS recurrence

Ductal carcinoma in-situ (DCIS) accounts for 20–25% of all new breast cancer diagnoses. DCIS has an uncertain risk of progression to invasive breast cancer and a lack of predictive biomarkers may result in relatively high levels (~ 75%) of overtreatment. To identify unique prognostic biomarkers of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gosling, Sarah B., Arnold, Emily L., Davies, Samantha K., Cross, Hannah, Bouybayoune, Ihssane, Calabrese, Doriana, Nallala, Jayakrupakar, Pinder, Sarah E., Fu, Liping, Lips, Esther H., King, Lorraine, Marks, Jeffrey, Hall, Allison, Grimm, Lars J., Lynch, Thomas, Pinto, Donna, Stobart, Hilary, Hwang, E. Shelley, Wesseling, Jelle, Geraki, Kalotina, Stone, Nicholas, Lyburn, Iain D., Greenwood, Charlene, Rogers, Keith D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250538/
https://www.ncbi.nlm.nih.gov/pubmed/37291276
http://dx.doi.org/10.1038/s41598-023-33547-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250538/
https://www.ncbi.nlm.nih.gov/pubmed/37291276
http://dx.doi.org/10.1038/s41598-023-33547-8

Ejemplares similares